イスラエルの診断科専門医 — ページ2

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Dr. Zohar Dotan heads the Urology Department at Sheba Medical Center in Israel. He is a primary pioneer of robotic and laparoscopic urologic surgery. He specializes in treating complex cancers of the kidney, prostate, and bladder. Dr. Dotan leads the Israeli Uro-Oncology Society and holds a PhD in Genetics.

• Completed a specialized uro-oncology fellowship at Memorial Sloan Kettering in New York.
• Performs robotic radical nephrectomy and da Vinci robotic prostatectomy.
• Authored over 50 scientific publications on advanced urologic cancer treatments.
• Works at Sheba Medical Center, ranked 7th best hospital globally by Newsweek.

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Chief Physician of the Oncology Center, Oncologist

Dr. Pnina Langevich leads the National Center for Rheumatology at Sheba Medical Center. She is a former Vice President of the World Association of Rheumatologists. Forbes Israel has repeatedly named her among the country’s top doctors. Dr. Langevich treats severe cases of lupus, scleroderma, and rheumatoid arthritis.

• Served for 12 years as Vice President of the World Association of Rheumatologists.
• Functions as the Editor–in–Chief of the international medical journal Lupus.
• Specializes in managing treatment–resistant autoimmune and joint diseases.
• Works at Sheba Medical Center, ranked 7th worldwide by Newsweek in 2026.

Michael Lotem heads the Center for Melanoma and Cancer Immunotherapy at Hadassah Medical Center. He specializes in clinical and pediatric oncology. The doctor researches the anti-cancer immune response.

Melanoma Treatment & Research

Dr. Lotem treats melanoma using immunotherapies. He studies the SLAM family of receptors to improve how the immune system fights cancer. This research helps find new ways to target malignant cells. He leads a team of clinicians and translational researchers in Jerusalem.

The doctor uses patient-derived tissues and clinical data for his studies. This access lets his team move laboratory findings into patient care. Dr. Lotem also performs melanoma surgery and sarcoma immunotherapy. He has worked at Hadassah Medical Center since 1995.

Clinical Focus

• Melanoma treatment and surgery
• Sarcoma immunotherapy
• Cancer screening and diagnostics
• Immune response research

Work Experience

• Head of the Center for Melanoma and Cancer Immunotherapy – Hadassah Medical Center, Jerusalem
• Professor and clinician – Hadassah Medical Center since 1995

Specialization

• Clinical Oncology
• Pediatric Oncology
• Dermatology
• Immunology

Dr. Yosi Alkalay is the founder of micrographic surgery in Israel and a specialist in dermatology–venereology. He pioneered the layer-by-layer removal of skin tumors. The doctor practices at Assuta Medical Center where he treats skin cancer.

Specialization & Approach

Dr. Alkalay mastered the Mohs micrographic surgery method. This technique allows for the precise removal of skin oncopathologies — cancerous growths that require careful excision. The specialist removes cancerous tissue layer by layer to preserve healthy skin. He also treats various conditions including hemangiomas.

His approach combines aesthetic medicine with plastic surgery to achieve cosmetic results. Because he uses micrographic techniques, he minimizes scarring while ensuring complete tumor removal.

Education & Training

• Degree in Medicine – Tel Aviv Medical University, Israel
• Medical Degree – Houston Cancer Center, USA
• Advanced training in Mohs micrographic surgery

Scientific Work & Publications

Dr. Alkalay contributes to dermatological research. He has authored approximately 100 scientific and medical works. These publications describe techniques in skin cancer surgery and venereology. Additionally, he participates in international medical congresses to share his surgical findings.

Professional Memberships

• American Academy of Dermatology
• European Academy of Dermatology and Venereology
• Israeli Society of Dermatology and Venereology

Dr. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby specializes in treating relapsed and high-risk pediatric leukemias and lymphomas. He completed fellowships at Johns Hopkins and the U.S. National Cancer Institute.

• Medical Director of the Advanced Biotherapy Center at Sheba Medical Center.
• Authored over 240 scientific publications in pediatric hemato-oncology.
• Board-certified in both Pediatrics and Pediatric Hematology and Oncology.
• Leads the integration of CAR T–cell therapy with bone marrow transplantation.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.